NCT06351462View on ClinicalTrials.gov

Comparative Health Status and Quality of Life of Patients With Sickle Cell Disease (SCD) Who Underwent Matched-sibling Hematopoietic Stem Cell Transplantation Versus Non Transplanted SCD Case-control Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2027

Conditions
Sickle Cell Disease
Interventions
OTHER

Spermogram

Spermogram will be proposed to men

OTHER

Hospital Anxiety and Depression Scale (HADS)

Anxiety and depression will be evaluated 10 years after HSCT

OTHER

SF36 Quality of life questionnaire

Quality of life will be evaluated 10 years after HSCT

OTHER

Psychologist interview

During a follow-up visit

OTHER

Optional sera banking

One in the study

OTHER

Optional DNA banking

Once in the study

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06351462 - Comparative Health Status and Quality of Life of Patients With Sickle Cell Disease (SCD) Who Underwent Matched-sibling Hematopoietic Stem Cell Transplantation Versus Non Transplanted SCD Case-control Patients | Biotech Hunter | Biotech Hunter